Thrombophilic tests (units of measurement) | Results | Normal range |
---|---|---|
Protein C (antigen) (%) | 99% | 60–125 |
Protein S (antigen) (%) | 102% | 60–125 |
Antithrombin (activity) (%) | 105% | 80–120 |
Activated protein C resistance (Bertina) | 0,90 | >0,77 |
Anti-cardiolipin antibodies IgG (U/GPL) | 4 | <7 |
Anti-cardiolipin antibodies IgM (U/MPL) | 2 | <4 |
Lupus anticoagulant | absent | absent |
Plasminogen activator inhibitor type 1 (ng/dl) | 30 | 4–44 |
PTHRA20210 gene polimorphism | wild type | wild type |
Factor V Leiden gene polimorphism | wild type | wild type |
Apolipoprotein B gene polimorphism C9774T and G3775A | wild type | wild type |
Apolipoprotein E gene polimorphism C3932T and C4070T | wild type | wild type |
Methylene-tetrahydrofolate C677T gene polimorphism | heterozigosity | wild type |
Angiotensin converting enzyme deletion gene polimorphism | insertion/deletion | insertion/insertion |
Homocysteinemia (μM) | 22 | 5–15 |
Prothrombin time (INR) | 0.95 | 0.8–1.2 |
Activated partial thromboplastin time (ratio) | 0.92 | 0.8–1.2 |
Fibrinogen (mg/dl) | 305 | 220–400 |
D-dimer (ug/l) | 188 | 0–198 |